Promidian Survey Finds Growing Support for Patient-Centered Medical Home

BERKELEY HEIGHTS, N.J., March 29, 2011 /PRNewswire/ -- Promidian, a management consulting firm focused on the pharmaceutical and biotechnology industries, today announced top-line survey findings about the increasing interest in the patient-centered medical home (PCMH), a patient-centric delivery-of-care model that is rapidly gaining nationwide attention for its potential to improve quality and access to health care—while reducing costs.

The Promidian PCMH survey was completed in March 2011 and included a nationwide mix of 181 stakeholders, including physicians, medical directors, nurses, and administrators and executives from medical group practices, health plans, pharmaceutical companies, and employer groups. The survey found that

• Patient engagement in care, access to care, and a team approach to care are viewed as the most important components of a PCMH;
• Priority disease states highlighted by PCMHs include diabetes, cardiovascular disease, asthma, obesity, and stroke;
• Medication adherence is viewed as extremely important to the success of a PCMH, and PCMHs are considering and evaluating a number of tactics to improve medication adherence;
• The vast majority of PCMH representatives are interested in receiving targeted resources to help achieve or maintain accreditation (eg, programs, tools, and training).

"Our survey identified a number of key priorities and challenges for PCMHs, as well as highlighted opportunities for pharmaceutical companies to positively influence and support the evolution of this innovative care delivery model," said Kevin Barnett, Executive Vice President and Managing Director for Promidian.

The complete results of the survey will be available at the Promidian exhibit booth at the Patient-Centered Primary Care Collaborative (PCPCC) Conference on March 29-31, at the Ronald Reagan Building, International Trade Center in Washington, DC.

About Promidian

Promidian is a management consulting firm that is focused on the pharmaceutical, biotechnology, and life sciences industries. We combine deep industry and functional area knowledge with specialized expertise in market assessment, analytics, and strategy development—to assist life sciences executives in addressing their most pressing business challenges.

For more information on the PCMH survey or to learn more about Promidian's service offerings, please contact Kevin Barnett, Executive Vice President, at [email protected], or visit our Web site at www.promidianconsulting.com.

Promidian is a company of the Access Group (www.theaccessgroup.com).

SOURCE Promidian